AstraZeneca Plc failed to win a U.S. panel�"s backing to introduce an improved version of its $1 billion-a-year medicine to prevent a respiratory disease that sends 125,000 babies to hospitals each year....
Read More...
[Source: BusinessWeek.com -- ]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment